A Randomized Controlled Dose-Escalation Study of LY06006, a Recombinant Humanized Monoclonal Antibody to RANKL, in Chinese Healthy Adults
Frontiers in pharmacology（2022）
关键词
pharmacokinetics,pharmacodynamics,immunogenicity,denosumab,RANK,RANKL,osteoporosis
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要